The landscape of food safety in Southeast Asia is shifting toward higher accountability and more rigorous oversight. On January 6, 2025, the Indonesian Food and Drug Authority (Badan Pengawas Obat dan Makanan) officially enacted a pivotal BPOM regulation regarding the Recall and Destruction of Processed Food. This update is not
The Indonesian healthcare landscape is undergoing a monumental shift. Under the leadership of President Prabowo Subianto, the nation is moving away from a purely curative model toward a proactive, preventive health paradigm. Central to this transformation is the expansion of the Free Health Check (CKG) program, an ambitious initiative aiming
Beyond the FDA and CE Mark: Why Early Market Entry in the World’s Fourth Most Populous Nation Can Strengthen Valuation and De-Risk Commercialization The 2026 Capital Environment: From Scientific Promise to Industrial Readiness Between 2020 and 2022, venture capital allocation into medical technology was heavily thesis-driven. A strong intellectual property
Common halal certification mistakes in Indonesia are one of the most expensive reasons why foreign companies have to wait, get turned down, or cannot enter the market. Many exporters don’t mean to break the rules; they just don’t understand how Indonesia’s halal system works in real life. Indonesia treats halal
As Indonesia’s market for Natural Medicines (OBA) and Health Supplements (SK) continues to surge, the BPOM Directorate of Supervision of Traditional Medicines and Health Supplements has intensified its focus on a “silent” danger: Heavy Metal Contamination. Unlike bacteria, heavy metals cannot be killed with heat; they are invisible, tasteless, and
The global Halal Products market is entering a transformative era. Valued at USD 2.3 trillion in 2026, the industry is projected to skyrocket to USD 4.5 trillion by 2033, growing at a robust CAGR of 8.5%. A combination of demographic shifts, strict new regulatory mandates, and a growing preference for
Is your product ready for the 2026 Halal deadline? In a significant move toward the full implementation of Indonesia’s Halal mandates, the Halal Product Assurance Organizing Body (BPJPH) recently held a high-level coordination meeting (Rakor) with the Indonesian Food and Drug Authority (BPOM) and the Ministry of Health (Kemenkes). The
The recent collaboration between Indonesia’s National Agency of Drug and Food Control (BPOM) and the Guangxi Drug Administration marks a significant milestone in BPOM registration for Chinese pharmaceutical companies seeking structured and compliant entry into the Indonesian market. This partnership signals a deeper level of regulatory engagement between the two
The Indonesian National Agency of Drug and Food Control (BPOM) has officially issued a new regulation that governs the supervision of drugs and food circulated online, including on e-commerce platforms. The update comes as part of the government’s ongoing efforts to strengthen the safety, quality, and efficacy of products sold
Quasi-Drug Registration has emerged as a strategic entry pathway for Japanese manufacturers seeking to access Indonesia’s highly regulated healthcare and wellness market. Positioned between conventional pharmaceuticals and consumer health products, quasi drugs offer a regulatory middle ground that aligns well with Japan’s long-standing expertise in science-driven wellness solutions. For Japanese
The landscape of food safety in Southeast Asia is shifting toward higher accountability and more rigorous oversight. On January 6, 2025, the Indonesian Food and Drug Authority (Badan Pengawas Obat dan Makanan) officially enacted a pivotal BPOM regulation regarding the Recall and Destruction of Processed Food. This update is not
The Indonesian healthcare landscape is undergoing a monumental shift. Under the leadership of President Prabowo Subianto, the nation is moving away from a purely curative model toward a proactive, preventive health paradigm. Central to this transformation is the expansion of the Free Health Check (CKG) program, an ambitious initiative aiming
Beyond the FDA and CE Mark: Why Early Market Entry in the World’s Fourth Most Populous Nation Can Strengthen Valuation and De-Risk Commercialization The 2026 Capital Environment: From Scientific Promise to Industrial Readiness Between 2020 and 2022, venture capital allocation into medical technology was heavily thesis-driven. A strong intellectual property
Common halal certification mistakes in Indonesia are one of the most expensive reasons why foreign companies have to wait, get turned down, or cannot enter the market. Many exporters don’t mean to break the rules; they just don’t understand how Indonesia’s halal system works in real life. Indonesia treats halal
As Indonesia’s market for Natural Medicines (OBA) and Health Supplements (SK) continues to surge, the BPOM Directorate of Supervision of Traditional Medicines and Health Supplements has intensified its focus on a “silent” danger: Heavy Metal Contamination. Unlike bacteria, heavy metals cannot be killed with heat; they are invisible, tasteless, and
The global Halal Products market is entering a transformative era. Valued at USD 2.3 trillion in 2026, the industry is projected to skyrocket to USD 4.5 trillion by 2033, growing at a robust CAGR of 8.5%. A combination of demographic shifts, strict new regulatory mandates, and a growing preference for
Is your product ready for the 2026 Halal deadline? In a significant move toward the full implementation of Indonesia’s Halal mandates, the Halal Product Assurance Organizing Body (BPJPH) recently held a high-level coordination meeting (Rakor) with the Indonesian Food and Drug Authority (BPOM) and the Ministry of Health (Kemenkes). The
The recent collaboration between Indonesia’s National Agency of Drug and Food Control (BPOM) and the Guangxi Drug Administration marks a significant milestone in BPOM registration for Chinese pharmaceutical companies seeking structured and compliant entry into the Indonesian market. This partnership signals a deeper level of regulatory engagement between the two
The Indonesian National Agency of Drug and Food Control (BPOM) has officially issued a new regulation that governs the supervision of drugs and food circulated online, including on e-commerce platforms. The update comes as part of the government’s ongoing efforts to strengthen the safety, quality, and efficacy of products sold
Quasi-Drug Registration has emerged as a strategic entry pathway for Japanese manufacturers seeking to access Indonesia’s highly regulated healthcare and wellness market. Positioned between conventional pharmaceuticals and consumer health products, quasi drugs offer a regulatory middle ground that aligns well with Japan’s long-standing expertise in science-driven wellness solutions. For Japanese
Enter your email to get the document delivered to your inbox.
